Effect of diabetes type on long‐term outcome of epidermal axon regeneration

by Mohammad Khoshnoodi, Shaun Truelove, Michael Polydefkis
Published 2019-10-01

Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression

by David Adams, Vincent Algalarrondo, Michael Polydefkis, Nitasha Sarswat, Michel S. Slama, Jose Nativi-Nicolau
Published 2021-10-01

Ethoxyquin is neuroprotective and partially prevents somatic and autonomic neuropathy in db/db mouse model of type 2 diabetes

by Ying Liu, Yuan Sun, Osefame Ewaleifoh, Josh Wei, Ruifa Mi, Jing Zhu, Ahmet Hoke, Michael Polydefkis
Published 2021-05-01

Cutaneous collateral axonal sprouting re-innervates the skin component and restores sensation of denervated Swine osteomyocutaneous alloflaps.

by Zuhaib Ibrahim, Gigi Ebenezer, Joani M Christensen, Karim A Sarhane, Peter Hauer, Damon S Cooney, Justin M Sacks, Stefan Schneeberger, W P Andrew Lee, Michael Polydefkis, Gerald Brandacher
Published 2013-01-01

A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis

by Teresa Coelho, David Adams, Isabel Conceição, Márcia Waddington-Cruz, Hartmut H. Schmidt, Juan Buades, Josep Campistol, John L. Berk, Michael Polydefkis, Jing Jing Wang, Jihong Chen, Marianne T. Sweetser, Jared Gollob, Ole B. Suhr
Published 2020-07-01